COVID-19 - April 7, 2020
Green light for trial study on using blood plasma from recovered COVID-19 patients
In a small clinical trial just granted approval, about 30 COVID-19 patients at Karolinska University Hospital may soon begin to receive blood plasma from people who have recovered from the disease. Sweden’s Ethical Review Authority has approved the trial treatment, and its effectiveness will be evaluated in a study by researchers at Karolinska Institutet and […]
COVID-19 - March 28, 2020
Karolinska Institutet is strengthening its healthcare capacity in virus diagnostics
Through cooperation with a Chinese supplier, financial support from the Knut and Alice Wallenberg Foundation and coordination with the healthcare sector, Karolinska Institutet (KI) aims to strengthen healthcare capacity in virus diagnostics. Karolinska Institutet’s capabilities are now being coordinated with the healthcare sector’s resources for COVID-19 diagnostics. The coordination is taking place through a collaboration […]
Collaboration - March 12, 2020
Zelluna and Karolinska Institutet collaborate
Zelluna Immunotherapy and Karolinska Institutet have announced a collaboration to develop next generation TCR-NK products for the treatment of patients with solid cancers. In addition, Zelluna is entered as a collaborative partner in the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy (“NextGenNK”) being established at the KI. Next generation TCR guided NK cells […]
Uncategorized - March 12, 2020
A better understanding of the human brain
An international team of scientists led by researchers at Karolinska Institutet has launched a comprehensive overview of all proteins expressed in the brain, published in the journal Science. The open-access database offers medical researchers an unprecedented resource to deepen their understanding of neurobiology and develop new, more effective therapies and diagnostics targeting psychiatric and neurological […]
Funding - October 11, 2019
Researchers at Karolinska Institutet awarded EUR 19 million in ERC Synergy Grants
Two research projects at the institute have been awarded synergy grants from the European Research Council (ERC). In total, the researchers and their international partners were awarded about EUR 19 million (SEK 209 million) over a six-year period for studies that aim to widen our understanding of disease-causing fat cells and unlock new cancer treatments. […]
Uncategorized - October 9, 2019
Research breakthrough in sex chromosome regulation
Researchers at Karolinska Institutet have uncovered a chromosome-wide mechanism that keeps the gene expression of sex chromosomes in balance in our cells. The findings shed light on molecular reasons for early miscarriage and could be important for the emerging field of regenerative medicine, states Karolinska Institutet in their press release. One active copy per cell […]
